The digital genome comprises of a total computerized assortment of DNA material that happens inside an organic entity or a cell. It's an easier technique to gather hereditary information concerning innate problems and is utilized broadly by geneticists for a more critical glance at likely hereditary diseases. It was first planned to be a device of analysis however has advanced into an amazing exploration apparatus.
The developing fame of the human genome projects is an excellent factor energizing the development of the digital genome market. As indicated by Forbes, by 2025, it's projected that 100 million genomes will be sequenced. Expanding financing for genomics is another main consideration in enlarging the market development. Additionally, developing improvement in the field of biotechnology because of rising medical care needs and expanding speculation by the public authority is again driving the market development. Furthermore, the developing interest for customized drugs combined with the infiltration of new players and new businesses across creating economies is likewise projected to cultivate market development. Moreover, the expanding commonness of the ongoing illness is additionally projected to impel the development of the digital genome market.
North America is expected to gain significant growth over the forecast period and this is attributed to the increasing research and development in biotechnology in the region. Moreover, the continuous launch of innovative products in the field of the digital genome is again expected to fuel the regional market growth. For instance, in October 2019, Inscripta, Inc., announced the launch of the Onyx™ Digital Genome Engineering platform. It is a fully automated benchtop instrument for genome-scale engineering. The CRISPR-mediated, massively parallel platform — which includes software, consumables, instrument, and assays — enables researchers to engineer microbial libraries containing the full breadth and scope of possible edit types, in their own labs.
Key Developments:
1. In August 2020, Ancestry has launched an AncestryHealth powered by Next Generation Sequencing,” the tool can screen for genes associated with breast cancer, heart disease, colon cancer, and blood disorders.
2. in October 2019, MGI has launched its new one-stop sequencing solution, including the portable "express" sequencing system DNBSEQ E series, the modular "digital biolab" DNBelab D series for use with the sequencing system, and a new single "cell" DNBelab C series, a handheld single-cell laboratory that can fit into a pocket.
3. In February 2020, Twist Bioscience launches twist targeted methylation sequencing solution to study methylation pattern changes in a wide range of research fields including cancer, epigenetics, and non-invasive prenatal testing
No comments:
Post a Comment